RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Radiopharm Theranostics Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Sep 30, 2026
$0.96−0.07 (-6.50%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Radiopharm Theranostics has not reported a dividend
No dividend per share appears in Radiopharm Theranostics's annual filings since fiscal 2022.